Euclidean Capital’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.58M | Hold |
|
|||||
|
2023
Q4 | $852K | Hold |
|
|||||
|
2023
Q3 | $1.06M | Buy |
|
|||||
|
2023
Q2 | $1.93M | Hold |
|
|||||
|
2023
Q1 | $3.05M | Hold |
|
|||||
|
2022
Q4 | $3.75M | Hold |
|
|||||
|
2022
Q3 | $9.77M | Hold |
|
|||||
|
2022
Q2 | $9.57M | Hold |
|
|||||
|
2022
Q1 | $11.4M | Hold |
|
|||||
|
2021
Q4 | $13.2M | Sell |
|
|||||
|
2021
Q3 | $17.5M | Sell |
|
|||||
|
2021
Q2 | $29.4M | Hold |
|
|||||
|
2021
Q1 | $43.4M | Sell |
|
|||||
|
2020
Q4 | $63.1M | Buy |
|